Question 1

What are the specific goals of this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) clinical trial (NCT05307939). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my HPV ctDNA levels be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) clinical trial (NCT05307939). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential benefits and risks of participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) clinical trial (NCT05307939). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this trial compare to standard treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) clinical trial (NCT05307939). Contact the study team or your healthcare provider for specific answers.

Question 5

What will my treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) clinical trial (NCT05307939). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) clinical trial (NCT05307939). Contact the study team or your healthcare provider for specific answers.

What this study is about